We Can Help

The costs of mesothelioma can be overwhelming. They can include income loss, expensive treatments that may not be covered by health insurance, plus pain and suffering for you and for your family. Because the disease is preventable – and because it is usually caused by someone else’s negligence – legal options may be available to help regain these costs. Asbestos lawyers focus their practice on knowledgeably and effectively bringing to justice companies that exposed employees and the public to asbestos products. A mesothelioma attorney can help you consider your options and file a claim against the company responsible for your asbestos-related illness. More than one company may be responsible. A mesothelioma attorney identifies all companies at fault. Mesothelioma lawsuits have helped thousands of people receive financial assistance. A lawsuit can result in much-needed money to help reduce financial hardships during an illness and can also provide a more stable future for your loved ones. A lawyer specializing in asbestos litigation can help you seek compensation for expenses related to illness caused by asbestos exposure.

Early Detection of Mesothelioma Lies in HMGB1 Isoforms

An international research team is exploring how variants of an important blood protein could be the key to prevention and early detection of malignant mesothelioma. Dr. Haining Yang at the University of Hawaii Cancer Center is leading the research and recently presented potential strategies at the 6th International Symposium on Malignant Pleural Mesothelioma. Previously, Yang…

The post Early Detection of Mesothelioma Lies in HMGB1 Isoforms appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

New Mesothelioma Biomarker Shows Promise

A new biomarker (FGF18) has shown promise for patients with pleural mesothelioma according to a paper presented at the World Conference on Lung Canter. […]

Atezolizumab Approved for Non-Small Cell Lung Cancer Patients

PD-L1 inhibitor atezolizumab has been approved for use with chemotherapy-refractory metastatic Non-Small Cell Lung Cancer patients. […]

Atezolizumab Approved for Non-Small Cell Lung Cancer Patients

PD-L1 inhibitor atezolizumab has been approved for use with chemotherapy-refractory metastatic Non-Small Cell Lung Cancer patients. […]

New Study Shows DNA Screening Can Help With Mesothelioma Treatment

Recently published results from a clinical trial show DNA screening may help doctors more effectively treat mesothelioma patients using chemotherapy. […]

New Study Shows DNA Screening Can Help With Mesothelioma Treatment

Recently published results from a clinical trial show DNA screening may help doctors more effectively treat mesothelioma patients using chemotherapy. […]

Study: Onconase, Malaria Drug Extends Mesothelioma Survival

A new treatment combining two existing drugs — one derived from frog eggs and another given to combat malaria — may be the key to extending mesothelioma survival. Scientists at Tongji University in Shanghai, China, discovered that mixing Onconase, an enzyme present in early-stage leopard frog embryos, with antimalarial drug dihydroartemisinin (DHA) synergistically suppressed growth…

The post Study: Onconase, Malaria Drug Extends Mesothelioma Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

FDA Fast Tracks New Pleural Mesothelioma Drug

The U.S. Food & Drug Administration (FDA) has decided to fast track SELLAS™ Life Sciences’ new drug Galinpepimut-S to treat pleural mesothelioma […]

Phase II Trial for New Mesothelioma Treatment Opens to Patients

A Phase II clinical trial testing a new treatment for mesothelioma is now open to patients at Baylor College of Medicine Treatment Center. […]

Promising Clinical Trial Results For A Mesothelioma Immunotherapy Drug

Promising results from another phase of a clinical trial for an immunotherapy drug for mesothelioma, CRS-207, have been released. […]

Verastem Mesothelioma Clinical Trial Stopped Early For Futility

The Boston-based company Verastem has stopped its mesothelioma clinical trial early due to futile results in the Phase 2 study of VS-6063. […]

New Statistical Model To Identify Ideal Mesothelioma Patients For Surgery

A doctor from Regina Elena National Cancer Institute has developed a new statistical model to help identify which mesothelioma patients could benefit most from surgery. […]

Mesothelioma Study Identifies Four Biomarkers That May Help Speed Up Diagnoses and Treatment

Scientists Identify Four Biomarkers That May Improve Mesothelioma Diagnostics […]

Man’s Death Proves Even a Little Asbestos Exposure Can Be Deadly

The deceased once worked in a factory where he cut asbestos materials, but only for 2 days. […]

Potential Mesothelioma Drug Wins Orphan Status from the European Commission

Cambridge, Mass.-based Verastem hopes to bring to the table a new treatment option for patients with asbestos-caused cancer […]